Recruiting
Phase 1
Phase 2

Pacritinib in CMML

Sponsor:

Douglas Tremblay

Code:

NCT06159491

Conditions

Chronic Myelomonocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pacritinib

Azacitidine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information